Stemina Launches Large Autism Diagnostic Study
 /  News / Stemina Launches Large Autism Diagnostic Study

Stemina Launches Large Autism Diagnostic Study

With a new $2.7 million federal grant in hand, Stemina Biomarker Discovery has launched a 1,500-patient study of its experimental test to diagnose children with autism spectrum disorder. According to the company, it’s the largest clinical trial ever of this type of autism test—one that measures residues in the blood called metabolites.

Read More

Related Posts

(608) 204-0104

504 S. Rosa Rd. Suite 150
Madison, WI 53719

contact@NeuroPointDx.com